Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.
|Articles|June 9, 2016
Overheard at ACOG 2016
Here's what the staff of Contemporary OB/GYN overheard while attending the ACOG 2016 annual meeting.
Advertisement
The 2016 Annual Clinical and Scientific Meeting for the American College of Obstetricians and Gynecologists held in Washington, DC last month brought new insights, lively debates, and more. Here's a sample of what the Contemporary OB/GYN staff overheard during the meeting.
Advertisement
Related to this article
Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Jessica Shepherd, MD, MBA, FACOG, joins Missed & Dismissed to discuss why perimenopause is overlooked and how disparities shape who gets care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG advises against GLP-1 receptor agonists during pregnancy
2
Matthew Nudy, MD, on estrogen and the cardiovascular system
3
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
4
Susan Reed, MD, on the future of menopause research and funding
5